Most patients with type 2 diabetes stop taking their medication within a year, and nearly one-third stop within the first 3 months. Also today, the FDA approves Ajovy for migraine prevention, some teens are using cannabis in their vapor devices, and alpha-blocker use is still common and still risky.
Amazon AlexaApple PodcastsSpotify
We noticed you have an ad blocker enabled. Please whitelist us so we can continue to provide free content.